LymphomaAntineoplastic Combined Chemotherapy ProtocolsLymphoma, B-CellLymphoma, Non-HodgkinLymphoma, T-CellLymphoma, Large B-Cell, DiffuseLymphoma, FollicularChemotherapy, AdjuvantBurkitt LymphomaLymphoma, B-Cell, Marginal ZoneCyclophosphamideCombined Modality TherapyDoxorubicinLymphoma, Mantle-CellAntineoplastic AgentsLymphoma, T-Cell, CutaneousTreatment OutcomeLymphoma, AIDS-RelatedLymphoma, T-Cell, PeripheralHodgkin DiseaseLymphoma, Large-Cell, AnaplasticCisplatinDisease-Free SurvivalPrognosisEtoposideNeoplasm StagingSurvival AnalysisSurvival RateNeoadjuvant TherapyMethotrexateBreast NeoplasmsLymphoma, Large-Cell, ImmunoblasticDrug Administration ScheduleAntibodies, Monoclonal, Murine-DerivedBleomycinLung NeoplasmsVinblastineNeoplasm Recurrence, LocalTransplantation, AutologousCarboplatinCytarabineNeoplasmsDrug Resistance, NeoplasmIfosfamideVincristineSalvage TherapyPaclitaxelInduction ChemotherapyFollow-Up StudiesAntigens, CD20Antibodies, MonoclonalTaxoidsTranslocation, GeneticAntimetabolites, AntineoplasticLymphoma, Extranodal NK-T-CellPrednisoneAntineoplastic Agents, AlkylatingTumor Markers, BiologicalDeoxycytidineCentral Nervous System NeoplasmsCell Line, TumorImmunohistochemistryOrganoplatinum CompoundsTime FactorsAnthracyclinesRecurrenceRadiotherapyStomach NeoplasmsFatal OutcomeTesticular NeoplasmsNeoplasm MetastasisHematopoietic Stem Cell TransplantationCarmustineRadiotherapy, AdjuvantKaplan-Meier EstimateDacarbazineChromosomes, Human, Pair 14ImmunophenotypingChemotherapy, Cancer, Regional PerfusionCarcinoma, Non-Small-Cell LungLymph NodesAntigens, CD30Thymus NeoplasmsOvarian NeoplasmsMediastinal NeoplasmsAntineoplastic Agents, PhytogenicProspective StudiesAdenocarcinomaAntibiotics, AntineoplasticHerpesvirus 4, HumanBrain NeoplasmsNauseaVomitingB-LymphocytesClinical Trials as TopicChromosomes, Human, Pair 18LeukemiaGranulocyte Colony-Stimulating FactorMitoxantroneNeutropenia